Published on

Medicine – Coagulation Disorders: The Coagulation Cascade

The coagulation cascade is a series of enzymatic reactions involving clotting factors that culminates in the formation of a stable fibrin clot.

It is traditionally divided into three pathways:

  1. Extrinsic pathway – initiated by tissue factor.
  2. Intrinsic pathway – classically initiated by contact activation.
  3. Final common pathway – generates thrombin and fibrin.
Important Clinical Principle

The intrinsic and extrinsic pathways converge at factor X activation. Factor Xa promotes thrombin generation, thrombin converts fibrinogen into fibrin, and factor XIIIa cross-links fibrin to stabilise the clot.

1. The Coagulation Cascade – Detailed Diagram

The following diagram illustrates the classical coagulation cascade, including the coagulation factors, cofactors and final fibrin cross-linking step.

Coagulation System Extrinsic Pathway Measured by PT / INR Tissue Factor (III) Factor VII → VIIa Ca²⁺ + phospholipids Intrinsic Pathway Measured by aPTT Factor XII → XIIa Factor XI → XIa Factor IX → IXa Intrinsic Tenase Complex FIXa + FVIIIa Ca²⁺ + phospholipids Factor X → Xa Common Pathway Prothrombin (II) → Thrombin (IIa) Factor Xa + Va + Ca²⁺ + phospholipids Fibrinogen (I) → Fibrin TT XIII → XIIIa Cross-linking Stable Fibrin Clot

Figure 1. Simplified classical coagulation cascade. Tissue factor initiation is central to physiological haemostasis; factor XII contact activation is particularly relevant to laboratory aPTT testing. The diagram illustrates the main reactions rather than every feedback and amplification step.

2. Extrinsic Pathway

The extrinsic pathway is initiated when vascular injury exposes tissue factor (factor III) to circulating blood.

Mechanism

  1. Tissue factor becomes exposed following vascular injury.
  2. Tissue factor binds factor VII/VIIa.
  3. The tissue factor–factor VIIa complex acts in the presence of calcium and phospholipids.
  4. Factor X is activated to factor Xa.
  5. The common pathway is initiated.
Laboratory Investigation: Prothrombin time (PT) measures the extrinsic and common pathways. PT is particularly sensitive to factor VII deficiency and is used to monitor warfarin therapy through INR.

3. Intrinsic Pathway

The intrinsic pathway is classically represented by sequential activation of factors XII, XI and IX, followed by formation of the intrinsic tenase complex.

Sequence of Activation

  1. Factor XII is activated to factor XIIa in the classical contact pathway.
  2. Factor XIIa activates factor XI to XIa.
  3. Factor XIa activates factor IX to IXa.
  4. Factor IXa combines with factor VIIIa, calcium and phospholipids.
  5. The intrinsic tenase complex activates factor X.
Laboratory Investigation: Activated partial thromboplastin time (aPTT) assesses the intrinsic and common pathways.
Important Clarification: Factor XII deficiency may markedly prolong aPTT but usually does not cause clinical bleeding. The classical intrinsic pathway is useful for interpreting coagulation tests, although physiological haemostasis is primarily initiated through tissue factor.

4. Final Common Pathway

Both intrinsic and extrinsic pathways converge at the activation of factor X.

Sequence of Events

  1. Factor X is activated to factor Xa.
  2. Factor Xa combines with factor Va, calcium and phospholipids to form the prothrombinase complex.
  3. Prothrombin (factor II) is converted into thrombin (factor IIa).
  4. Thrombin converts fibrinogen (factor I) into fibrin.
  5. Thrombin activates factor XIII to XIIIa.
  6. Factor XIIIa cross-links fibrin, producing a stable clot.

Common Pathway Flowchart

Factor X → Xa Convergence of both pathways Prothrombinase Complex Factor Xa + Va + Ca²⁺ + phospholipids Prothrombin → Thrombin Factor II → IIa Fibrinogen → Fibrin Factor I converted to fibrin Stable Fibrin Clot Factor XIIIa-mediated cross-linking

5. Important Coagulation Factors and Associated Disorders

Factor Name / Function Clinical Significance
IFibrinogenHypofibrinogenaemia or afibrinogenaemia
IIProthrombinProthrombin deficiency
IIITissue factorInitiates tissue factor pathway
IVCalciumRequired for several coagulation reactions
VProaccelerinCofactor in prothrombinase complex
VIIProconvertinDeficiency typically prolongs PT
VIIIAntihaemophilic factor AHaemophilia A
IXChristmas factorHaemophilia B
XStuart–Prower factorCommon-pathway deficiency
XIPlasma thromboplastin antecedentFactor XI deficiency (haemophilia C)
XIIHageman factorProlonged aPTT, usually without bleeding
XIIIFibrin-stabilising factorDelayed bleeding; PT and aPTT usually normal

6. Coagulation Tests and Pathways

Investigation Pathway Assessed Important Abnormalities
PTExtrinsic and commonWarfarin, vitamin K deficiency, factor VII deficiency, liver disease, DIC
aPTTIntrinsic and commonHaemophilia A/B, heparin, lupus anticoagulant
TTFibrinogen-to-fibrin conversionHeparin, direct thrombin inhibitors, fibrinogen abnormalities
Bleeding timePrimary haemostasis (historical test)Platelet dysfunction, thrombocytopenia, VWD

7. Vitamin K-Dependent Coagulation Factors

Vitamin K is required for the gamma-carboxylation of several coagulation proteins, allowing them to bind calcium and function normally.

Vitamin K-Dependent Coagulation Factors:

II, VII, IX, X

Proteins C and S are also vitamin K-dependent anticoagulant proteins.

Warfarin inhibits vitamin K recycling and reduces the functional activity of these proteins.

8. High-Yield Examination Summary

Feature Key Point
Extrinsic pathwayTissue factor and factor VII; assessed by PT
Intrinsic pathwayFactors XII, XI, IX and VIII; assessed by aPTT
Common pathwayFactors X, V, II and I
Haemophilia AFactor VIII deficiency
Haemophilia BFactor IX deficiency
Factor XIIICross-links fibrin; deficiency may have normal PT and aPTT
Vitamin K-dependent factorsII, VII, IX and X
Final clotCross-linked fibrin

9. Key Examination Pearls

  • Factor VIII deficiency = Haemophilia A.
  • Factor IX deficiency = Haemophilia B.
  • Factor VII belongs to the extrinsic pathway.
  • Factors VIII, IX, XI and XII belong to the intrinsic pathway in the classical cascade.
  • Factors I, II, V and X belong to the common pathway.
  • Factor XIII stabilises fibrin through cross-linking.
  • Calcium (factor IV) is required for several coagulation reactions.
  • Vitamin K-dependent factors are II, VII, IX and X.
  • Factor XII deficiency may prolong aPTT without causing clinical bleeding.
  • Factor XIII deficiency may cause bleeding despite normal PT and aPTT.
Most Important Examination Point

The intrinsic and extrinsic pathways converge at factor X activation. Factor Xa generates thrombin, thrombin converts fibrinogen into fibrin, and factor XIIIa cross-links fibrin to form a stable clot.

Clinical Note

The classical coagulation cascade is a useful model for interpreting PT and aPTT, but physiological haemostasis is more complex and depends on tissue factor initiation, platelet surfaces, thrombin amplification and endogenous anticoagulant mechanisms. Coagulation test results must therefore be interpreted alongside the patient's bleeding history and clinical findings.

Kembara Xtra – Medicine Revision Notes

Image description
0 Comments